Nouscom
Clinical-stage biotech developing neoantigen-based cancer immunotherapies.
€120MSeries D
Participant5V
5AM Ventures
Activity from announced rounds
All recorded activity
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $335M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in all activityMendra
Develops and commercializes rare disease therapies using AI
$82MSeries A
Role not disclosedKinaset Therapeutics
Develops inhaled therapies for severe respiratory diseases
$103MSeries B
Role not disclosedLatigo Biotherapeutics
Latigo Biotherapeutics develops non-opioid pain medicines that target peripheral pain signaling.
$150MSeries B
Participant